Screening of the Inhibitory Activity of Korea Local Plant Extracts against Indoleamine 2,3-dioxygenase (IDO) |
Jang, Jun-Pil
(Chemical Biology Research Center, Korea Research Institute of Bioscience and Biotechnology(KRIBB))
Jang, Jae-Hyuk (Chemical Biology Research Center, Korea Research Institute of Bioscience and Biotechnology(KRIBB)) Bae, Eun-Young (Chemical Biology Research Center, Korea Research Institute of Bioscience and Biotechnology(KRIBB)) Jeong, Sook-Jung (Chemical Biology Research Center, Korea Research Institute of Bioscience and Biotechnology(KRIBB)) Kim, Hye-Min (Chemical Biology Research Center, Korea Research Institute of Bioscience and Biotechnology(KRIBB)) Kim, Mee-Ree (Department of Food and Nutrition, Chungnam National University) Soung, Nak-Kyun (Chemical Biology Research Center, Korea Research Institute of Bioscience and Biotechnology(KRIBB)) Kim, Bo-Yeon (Chemical Biology Research Center, Korea Research Institute of Bioscience and Biotechnology(KRIBB)) Ahn, Jong-Seog (Chemical Biology Research Center, Korea Research Institute of Bioscience and Biotechnology(KRIBB)) |
1 | Munn, D. H. and Mellor, A. L. (2007) Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J. Clin. Invest. 117: 1147-1154. DOI ScienceOn |
2 | Mellor, A. L., Munn, D., Chandler, P., Keskin, D., Johnson, T., Marshall, B., Jhaver, K. and Baban, B. (2003) Tryptophan catabolism and T cell responses. Adv. Exp. Med. Biol. 527: 27-35. |
3 | Mellor, A. L. and Munn, D. H. (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4: 762-774. DOI ScienceOn |
4 | Taylor, M. W. and Feng, G. S. (1991) Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 5: 2516-2522. |
5 | Uyttenhove, C., Pilotte, L., Theate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T. and Van den Eynde, B. J. (2003) Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat. Med. 9: 1269-1274. DOI ScienceOn |
6 | Guillemin, G. J., Brew, B. J., Noonan, C. E., Takikawa, O. and Cullen, K. M. (2005) Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus. Neuropathol. Appl. Neurobiol. 31: 395-404. DOI ScienceOn |
7 | Fujigaki, Y., Sakakima, M., Sun, Y., Goto, T., Ohashi, N., Fukasawa, H., Tsuji, T., Yamamoto, T. and Hishida, A. (2007) Immunohistochemical study on caveolin-1alpha in regenerating process of tubular cells in gentamicin-induced acute tubular injury in rats. Virchows. Arch. 450: 671-681. DOI ScienceOn |
8 | Potula, R., Poluektova, L., Knipe, B., Chrastil, J., Heilman, D., Dou, H., Takikawa, O., Munn, D. H., Gendelman, H. E. and Persidsky, Y. (2005) Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis. Blood 106: 2382-2390. DOI ScienceOn |
9 | Mellor, A. L., Keskin, D. B., Johnson, T., Chandler, P. and Munn, D. H. (2002) Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses. J. Immunol. 168: 3771- 3776. |
10 | Friberg, M., Jennings, R., Alsarraj, M., Dessureault, S., Cantor, A., Extermann, M., Mellor, A. L., Munn, D. H. and Antonia, S. J. (2002) Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection. Int. J. Cancer 101: 151-155. DOI ScienceOn |
11 | Takikawa, O., Kuroiwa, T., Yamazaki, F. and Kido, R. (1988) Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzymemediated tryptophan degradation in its anticellular activity. J. Biol. Chem. 263: 2041-2048. |
12 | Takikawa, O. (2005) Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism. Biochem. Biophys. Res. Commun. 338: 12-19. DOI ScienceOn |